Evidence map›Paper›PMID 26880764›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

Mingce Zhang, Claudia Bracaglia, Giusi Prencipe, Christina J Bemrich-Stolz, Timothy Beukelman, Reed A Dimmitt, W Winn Chatham, Kejian Zhang, Hao Li, Mark R Walter and 3 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Role of DOCK8 in cytokine storm syndromes.The Journal of allergy and clinical immunology · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Anti-Interferon-γ Therapy for Cytokine Storm Syndromes.Advances in experimental medicine and biology · 2024
    Review
  12. Kawasaki Disease-Associated Cytokine Storm Syndrome.Advances in experimental medicine and biology · 2024
    Review
  13. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.Advances in experimental medicine and biology · 2024
    Review
  14. CD8Advances in experimental medicine and biology · 2024
    Review
  15. Immunology of Cytokine Storm Syndromes: Natural Killer Cells.Advances in experimental medicine and biology · 2024
    Review
  16. Genetics of Primary Hemophagocytic Lymphohistiocytosis.Advances in experimental medicine and biology · 2024
    Review
  17. Review
  18. Monocytic Phagocytes in the Immunopathogenesis of Cytokine Storm Syndromes.Advances in experimental medicine and biology · 2024
    Review
  19. Review
  20. Laboratory Features and Pathology of Cytokine Storm Syndromes.Advances in experimental medicine and biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Mingce ZhangDivision of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233;
Claudia BracagliaDivisione di Reumatologia Pediatrica, Ospedale Pediatrico Bambino Gesù, 00165 Rome, Italy;
Giusi PrencipeDivisione di Reumatologia Pediatrica, Ospedale Pediatrico Bambino Gesù, 00165 Rome, Italy;
Christina J Bemrich-StolzDivision of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL 35233;
Timothy BeukelmanDivision of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294;
Reed A DimmittDivision of Pediatric Gastroenterology, University of Alabama at Birmingham, Birmingham, AL 35233;
W Winn ChathamDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294;
Kejian ZhangHuman Genetics, University of Cincinnati, Cincinnati, OH 45229;
Hao LiDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294;ORCID http://orcid.org/0000-0002-4720-5471
Mark R WalterDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294; and.
Fabrizio De BenedettiDivisione di Reumatologia Pediatrica, Ospedale Pediatrico Bambino Gesù, 00165 Rome, Italy;
Alexei A GromDivision of Pediatric Rheumatology, University of Cincinnati, Cincinnati, OH 45229.
Randy Q CronDivision of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294; rcron@peds.uab.edu.
University of Alabama at Birmingham · USBambino Gesù Children's Hospital · ITUniversity of Cincinnati · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Prevention of Primary HCMV Infection by Vaccinating against HCMV-Encoded IL-10R01AI049342 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BARRY, PETER A, WALTER, MARK R · 2002 to 2017
$6.9M
Vaccine-mediated Targeting of Viral IL10 to Control HCMV Shedding and ReinfectionR01AI097629 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BARRY, PETER A, WALTER, MARK R · 2012 to 2016
$3.1M
MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic JuveniR01AR059049 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI GROM, ALEXEI A · 2011 to 2015
$1.7M
NIAID NIH HHS R01 AI049342NIAID NIH HHS R01 AI097629NIAMS NIH HHS P30 AR048311NIAMS NIH HHS R01 AR059049
6 · The paper itself

Abstract

Frequently fatal, primary hemophagocytic lymphohistiocytosis (HLH) occurs in infancy resulting from homozygous mutations in NK and CD8 T cell cytolytic pathway genes. Secondary HLH presents after infancy and may be associated with heterozygous mutations in HLH genes. We report two unrelated teenagers with HLH and an identical heterozygous RAB27A mutation (c.259G→C). We explore the contribution of this Rab27A missense (p.A87P) mutation on NK cell cytolytic function by cloning it into a lentiviral expression vector prior to introduction into the human NK-92 cell line. NK cell degranulation (CD107a expression), target cell conjugation, and K562 target cell lysis was compared between mutant- and wild-type-transduced NK-92 cells. Polarization of granzyme B to the immunologic synapse and interaction of mutant Rab27A (p.A87P) with Munc13-4 were explored by confocal microscopy and proximity ligation assay, respectively. Overexpression of the RAB27A mutation had no effect on cell conjugate formation between the NK and target cells but decreased NK cell cytolytic activity and degranulation. Moreover, the mutant Rab27A protein decreased binding to Munc13-4 and delayed granzyme B polarization toward the immunologic synapse. This heterozygous RAB27A mutation blurs the genetic distinction between primary and secondary HLH by contributing to HLH via a partial dominant-negative effect.

Indexed as

Mutation, MissenseAdolescentCell DegranulationCell LineCytoplasmic GranulesFemaleHeterozygoteHumansImmunoprecipitationKiller Cells, NaturalLymphohistiocytosis, HemophagocyticMaleMicroscopy, Confocalrab27 GTP-Binding Proteinsrab GTP-Binding ProteinsReverse Transcriptase Polymerase Chain ReactionRAB27A protein, humanrab27 GTP-Binding Proteinsrab GTP-Binding Proteins

Identifiers

PMID26880764
PMCPMC4779709
OpenAlexW2273582653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.